0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 201-220 of 497 Articles
Original Investigation |  FREE
Neda Ratanawongsa, MD, MPH; Andrew J. Karter, PhD; Melissa M. Parker, MS; et al.
JAMA Intern Med. 2013;173(3):210-218. doi:10.1001/jamainternmed.2013.1216.

Invited Commentary | 
Aanand D. Naik, MD
JAMA Intern Med. 2013;173(3):218-219. doi:10.1001/jamainternmed.2013.1229.

Viewpoint | 
B. Joseph Guglielmo, PharmD
JAMA Intern Med. 2013;173(3):184-185. doi:10.1001/jamainternmed.2013.1405.

Invited Commentary | 
Lawrence X. Yu, PhD; Gregory P. Geba, MD, MPH
JAMA Intern Med. 2013;173(3):208-209. doi:10.1001/jamainternmed.2013.2283.

Special Article | 
Jonas B. Green, MD, MPH, MSHS; Joseph S. Ross, MD, MHS; Cynthia A. Jackevicius, PharmD, MSc; et al.
JAMA Intern Med. 2013;173(3):229-232. doi:10.1001/jamainternmed.2013.1529.

Research Letters |  FREE
Eric G. Campbell, PhD; Genevieve Pham-Kanter, PhD; Christine Vogeli, PhD; et al.
JAMA Intern Med. 2013;173(3):237-239. doi:10.1001/jamainternmed.2013.1539.

Invited Commentary | 
Brian K. Alldredge, PharmD; Steven R. Kayser, PharmD
JAMA Intern Med. 2013;173(3):233-234. doi:10.1001/jamainternmed.2013.1777.

Perspectives |  FREE
Rita F. Redberg, MD, MSc
JAMA Intern Med. 2013;173(3):179. doi:10.1001/jamainternmed.2013.3378.

Original Investigation |  FREE
Tara Gomes, MHSc; Donald A. Redelmeier, MD; David N. Juurlink, MD, PhD; et al.
JAMA Intern Med. 2013;173(3):196-201. doi:10.1001/2013.jamainternmed.733.
Includes: Supplemental Content

Research Letters |  FREE
Maya Vijayaraghavan, MD, MAS; Joanne Penko, MS, MPH; David R. Bangsberg, MD, MPH; et al.
JAMA Intern Med. 2013;173(3):235-237. doi:10.1001/jamainternmed.2013.1576.
Includes: Supplemental Content

Editor's Correspondence | 
Douglas MacKay, ND
JAMA Intern Med. 2013;173(2):166-167. doi:10.1001/2013.jamainternmed.1028.

Editor's Correspondence | 
Donald M. Marcus, MD; Arthur P. Grollman, MD
JAMA Intern Med. 2013;173(2):166-167. doi:10.1001/jamainternmed.2013.1747.

Correction |  FREE
JAMA Intern Med. 2013;173(1):14. doi:10.1001/jamainternmed.2013.3143.

Editor's Correspondence | 
Michael Pazianas, MD
JAMA Intern Med. 2013;173(1):79-80. doi:10.1001/2013.jamainternmed.753.

Editor's Correspondence | 
Raphael P. H. Meier, MD; Rene Rizzoli, MD; Robin E. Peter, MD
JAMA Intern Med. 2013;173(1):79-80. doi:10.1001/jamainternmed.2013.1238.

Original Investigation |  FREE
Stephen F. Derose, MD, MS; Kelley Green, RN, PhD; Elizabeth Marrett, MPH; et al.
JAMA Intern Med. 2013;173(1):38-43. doi:10.1001/2013.jamainternmed.717.
Includes: CME, Supplemental Content

Invited Commentary | 
Michael A. Fischer, MD, MS
JAMA Intern Med. 2013;173(1):44-45. doi:10.1001/jamainternmed.2013.1821.

Original Investigation |  FREE
Dimitri M. Drekonja, MD, MS; Thomas S. Rector, PhD; Andrea Cutting, MA; et al.
JAMA Intern Med. 2013;173(1):62-68. doi:10.1001/2013.jamainternmed.829.
Includes: Supplemental Content

Original Investigation |  FREE
Alyce S. Adams, PhD; Connie Uratsu, RN; Wendy Dyer, MS; et al.
JAMA Intern Med. 2013;173(1):54-61. doi:10.1001/2013.jamainternmed.955.

Editorial |  FREE
Robert Steinbrook, MD
JAMA Intern Med. 2013;173(1):11-12. doi:10.1001/2013.jamainternmed.874.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA
Viewpoint  | 
Educational Opportunities With Postevent Debriefing
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.